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Bacteriophages (or phages) are the most abundant biological entities on earth, and are
estimated to outnumber their bacterial prey by ten-fold1. The constant threat of phage
predation has led to the evolution of a broad range of bacterial immunity mechanisms, which
in turn, result in the evolution of diverse phage immune evasion strategies leading to a
dynamic coevolutionary arms race2,3. Though bacterial innate immune mechanisms against
phage abound, the only documented bacterial adaptive immune system is the CRISPR/Cas
(Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR associated proteins)
system, which provides sequence-specific protection from invading nucleic acids including
phage4–11. Here we show a remarkable turn of events, in which a phage encoded CRISPR/
Cas system is used to counteract a phage inhibitory chromosomal island of the bacterial
host. A successful lytic infection by the phage is dependent on sequence identity between
CRISPR spacers and the target chromosomal island. In the absence of such targeting, the
phage encoded CRISPR/Cas system can acquire new spacers to rapidly evolve and ensure
effective targeting of the chromosomal island to restore phage replication.
Vibrio cholerae serogroup O1 is the primary causative agent of the severe diarrhoeal disease
cholera, and lytic V. cholerae phages have been implicated in impacting disease burden
particularly in the endemic region surrounding the Bay of Bengal12,13. We recently
described the isolation of the ICP1 (for the International Centre for Diarrhoeal Disease
Research, Bangladesh cholera phage 1) -related, V. cholerae O1-specific virulent
myoviruses that are omnipresent amongst cholera patient rice-water stool samples collected
at the ICDDR,B from 2001 to 201114 and current study. V. cholerae readily evolves resistance
to ICP1 predation through mutations in O1 antigen biosynthetic genes outside the human
host; however, this mutational escape comes at a cost as virulence necessitates maintenance
of the O1 antigen15. This dynamic between predation by ICP1 and virulence of V. cholerae
O1, specifically in the context of human infection, provides a unique opportunity for
discovery of novel bacterial immunity and phage immune evasion strategies. One bacterial
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defensive strategy against phages is the CRISPR/Cas system. CRISPR loci consist of an
array of short direct repeats separated by highly variable spacer sequences of precise length
corresponding to segments of previously captured foreign DNA (protospacers)4,7,9. CRISPR
loci are found in ~40% and ~90% of sequenced bacterial and archaeal genomes,
respectively8,16. The CRISPR array is transcribed and the transcript cleaved into small
CRISPR RNAs (crRNAs), that in conjunction with the Cas proteins, execute an efficient
process of immunity in which foreign nucleic acids are recognized by hybridization to
crRNAs and cleaved4,7,8.
We isolated eleven ICP1-related phages from stools of cholera patients at the
ICDDR,B14 and current study, five of which encode a CRISPR/Cas system located between
ORF 87 and ORF 88 of the ancestral ICP1 genome14. The GC content of this CRISPR/Cas
system is the same (~37%) as the rest of the ICP1 genome. The ICP1 CRISPR/Cas system
consists of two CRISPR loci (designated CR1 and CR2) and six cas genes (Fig. 1a) whose
organization and protein products are most homologous to Cas proteins of the type 1-F
(Yersinia pestis) subtype system17 (Supplementary Table 1). V. cholerae is divided into two
biotypes, classical and El Tor, the former of which is associated with earlier pandemics and
has since been replaced by the El Tor biotype18. The classical strain, V. cholerae O395, has
a CRISPR/Cas system belonging to the type I-E (Escherichia coli) subtype17, and to date
there has not been any description of El Tor strains possessing a CRISPR/Cas system. Thus,
the origin of the CRISPR/Cas system in ICP1 phage is unknown. Protospacer-adjacent
motifts (PAMs) are type specific, short conserved sequence motifs in the immediate vicinity
of protospacers that are required for acquisition and targeting7,9,11,19. In contrast to the GG
PAM reported for the type I-F CRISPR/Cas systems in bacteria19, the protospacers targeted
by the ICP1 CRISPR array display a GA PAM (Supplementary Fig. 1).
The majority of spacers in the ICP1 CRISPR show 100% identity to sequences within an 18
kb island found in a subset of V. cholerae strains that include the classical strain O395
isolated in India in 1964, El Tor strain MJ-1236 isolated in Bangladesh in 1994, and several
El Tor strains collected at the ICDDR,B between 2001–2011 (Supplementary Table 2). The
18 kb island resembles the phage inducible chromosomal islands (PICIs) of Gram-positive
bacteria, including the prototype Staphylococcus aureus pathogenicity islands (SaPIs)20,21.
SaPIs are induced to excise, circularize and replicate following infection by certain phages.
They use varied mechanisms to interfere with the phage reproduction cycle to enable their
own promiscuous spread21 and this can protect the surrounding bacterial population from
further phage predation. The organization of the V. cholerae 18 kb island targeted by the
ICP1 CRISPR/Cas system is similar in length, base composition, and organization to that
observed in the SaPIs subset of PICIs, with an integrase homologue at one end and a GC
content lower than that of the host species (37% compared to 47.5%). We therefore refer to
the 18 kb element as the V. cholerae PICI-like element (PLE) (Fig. 2).
To address the functional relevance of the ICP1 CRISPR/Cas system, we focused on the
interaction between the paired ICP1_2011_A phage and the V. cholerae O1 El Tor strain
(harboring PLE1) that were isolated from the same stool sample (for simplicity hereafter
referred to as ICP1 and V. cholerae PLE+). ICP1 has two CRISPR spacers (8 and 9) (Fig.
1b) that have 100% identity to sequences within the V. cholerae PLE (Fig. 2 and
Supplementary Table 2). Using the standard soft agar overlay method, we found that ICP1
can plaque efficiently on V. cholerae PLE+ (Fig. 3b). We used northern blot analysis to
confirm that ICP1 crRNAs are transcribed and processed during V. cholerae infection
(Supplementary Fig. 2). To test whether targeting of the PLE by the ICP1 CRISPR/Cas
system impacts phage fitness, we eliminated spacer 8 and 9 targeting. Spacer 8 targeting was
disrupted by introducing silent mutations into its target within the PLE, generating V.
cholerae PLE(8*) (Fig. 3a). We then infected this strain with a spontaneous ICP1 spacer 9
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deletion mutant, referred to as ICP1(ΔS9). ICP1(ΔS9) was blocked for plaque formation on
V. cholerae PLE(8*); however, it maintained wild type plaquing efficiency on V. cholerae
PLE+ (Fig. 3b). Importantly, V. cholerae PLE(8*) is sensitive to plaque formation by ICP1
(Fig. 3b), which still harbors one spacer (S9) targeting the PLE. These results demonstrate
that ICP1 CRISPR/Cas must target the PLE for destruction in order to effectively infect and
form plaques, and that a single spacer that targets the PLE is sufficient to facilitate
successful phage replication. A mutant in which PLE ORFs 7–20 were deleted was
susceptible to infection by ICP1(ΔS9) with wild type plaquing efficiency (Supplementary
Fig. 3). This demonstrates that an intact PLE is required to inhibit ICP1 in the absence of
CRISPR targeting. These results, in conjunction with the observation that PLE1 circularizes
following ICP1 infection (Supplementary Fig. 4), further support our designation of the 18
kb island as a PICI-like element.
It has been well documented in the type I-E (E. coli) system that CRISPR interference
requires an intact PAM and a fully complementary seed region (a noncontiguous 7 bp
sequence immediately adjacent to the PAM)22. To address the sequence requirements of the
ICP1 CRISPR/Cas system we constructed a series of point mutations in the spacer 8 target
in V. cholerae PLE that span the PAM, seed region, and remainder of the target sequence
and determined their impact on immunity. In accordance with previous results, we found
that single mutations within the PAM or the first four positions in the seed region
immediately adjacent to the PAM abolish ICP1 CRISPR/Cas immunity (Supplementary Fig.
5). Interestingly, mutations of increasing distance from the PAM showed a concordant
decreasing effect on immunity. Up to five mismatches outside of the seed region of the
target are known to be tolerated in the type I-E system22, and similarly we found that three
and five mutations outside of the seed region were tolerated, however, eight mutations were
not (Supplementary Fig. 5).
In experiments where the ICP1 CRISPR/Cas system could not target the V. cholerae PLE
and therefore plaque formation was greatly reduced, we observed phage escape mutants at
frequencies that were dependent upon the host strain on which the phage had been
previously propagated. When ICP1(ΔS9) was grown on a PLE+ host prior to plaquing on V.
cholerae PLE(8*), the efficiency of plaquing (EOP, which is the plaque count on the mutant
host strain divided by that on the wild-type host strain) was 3.5 × 10−5. The CRISPR loci
from ten independent ICP1(ΔS9) escape mutants were sequenced, and in all cases, a new
spacer was present at the leader end of the CRISPR CR1 array. Furthermore, the new
spacers had 100% identity to sequences within the PLE (Fig. 2), and all newly integrated
spacers target the PLE with the conserved GA dinucleotide PAM sequence (Supplementary
Fig. 1b). The experimentally acquired spacers target both the coding and noncoding strands
(Supplementary Table 3) although most (nine out of ten) target the coding strand. The pre-
existing spacer (S8) (although mismatched in these experiments) also targets the coding
strand; these data are in support of recent evidence that the DNA strand from which new
protospacers are incorporated is heavily biased towards the existing protospacer
orientation23,24. In contrast to when phage were propagated on a PLE+ host prior to plaquing
on V. cholerae PLE(8*), phage escape mutants were detected at a much lower frequency
(EOP=1.1 × 10−8) when ICP1(ΔS9) was grown on a V. cholerae PLE− host. This shows that
new spacers targeting the PLE are incorporated into the CRISPR array during ICP1(ΔS9)
infection of the PLE+ host (the immunization process), and that an immune host possessing
an untargeted PLE can subsequently be employed to select for new ICP1 CRISPR
acquisition events that confer targeting and thus restore phage replication. These results
demonstrate that the ICP1 CRISPR/Cas system is fully functional as an adaptive immune
evasion system that benefits the phage.
Seed et al. Page 3
Nature. Author manuscript; available in PMC 2013 August 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
ICP1 has evolved to effectively target the V. cholerae PLE with an adaptive immune evasion
system that has never before been shown to function in bacterial viruses. During ICP1
infection of V. cholerae PLE+, PLE circularizes (Supplementary Fig. 4) and inhibits ICP1
through an unknown mechanism. In order to successfully replicate, ICP1 uses the CRISPR/
Cas system to target the PLE for destruction and because host cell death and DNA damage
is inherent to lytic phage infection, CRISPR-mediated DNA cleavage of the PLE does not
negatively impact ICP1 infection. Sequencing data has been used to identify putative
CRISPR arrays within a Clostridium difficile prophage25, and more recently in
metagenomic data sets of free viruses26,27. However, there is currently no evidence for
expression or function of these putative arrays. We show that the ICP1-encoded CRISPR/
Cas system actively and autonomously functions to inhibit host immunity and thereby
permit lytic infection. The implications of this finding, in conjunction with the previous
observations regarding the presence of CRISPR loci in other phages25–27, suggest that the
use of the so-called bacterial adaptive immune system by these bacterial predators may be
an underappreciated immune evasion strategy in the unfolding phage versus host
coevolutionary arms race.
METHODS
Phage (ICP1_2011_A and ICP1_2006_E) and V. cholerae were isolated from cholera rice-
water stool samples and propagated as described14,15. Genomic libraries were generated for
phage and host strains as described28 and sequenced using an Illumina HiSeq2000. A V.
cholerae O1 El Tor isolate collected at the ICDDR,B in 2006, which was sequenced in this
study and found to not harbor a PLE, was used as the PLE- host for propagation
experiments. We used the CRISPRFinder program16 to identify CRISPR loci. WebLogo29
was used to generate sequence logos for identification of the PAM. Point mutations were
constructed using splicing by overlap extension PCR and introduced using pCVD442-lac as
previously described15. The PLE1 deletion construct (missing 8.6 kb including ORFs 7–20)
was constructed using the FLP/FRT site-specific recombination system30. ICP1(ΔS9) was
identified by screening for alterations in the CRISPR array by PCR following growth on V.
cholerae PLE+. RNA was purified using the mirVana kit (Ambion) at the indicated times
and run on 12% polyacrylamide urea gels. Northern blots were prehybridized in Ultrahyb-
oligo (Ambion) and hybridization was carried out at 37°C overnight using 32 nt 5′ end-
labeled DNA probes (generated with [γ-32P]ATP and T4 polynucleotide kinase)
complementary to spacers 8 and 6.
Supplementary Material
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Figure 1. Genomic organization of the ICP1 CRISPR/Cas system
a, The ICP1 phage CRISPR/Cas system consists of six cas genes and two CRISPR loci
(CR1 and CR2). b, For each CRISPR locus, the repeat (28 bp) and spacer (32 bp) content is
detailed as grey diamonds and colored rectangles, respectively. Repeats (28 bp) that match
the repeat consensus are shown in grey diamonds, and degenerate repeats are indicated in
hatched grey diamonds. An AT-rich leader sequence precedes each CRISPR locus (grey
rectangle). Spacers are colored according to the percent identity (solid represent 100%
identity, gradient represents 81–97% identity). A fifth ICP1-related phage (ICP1_2003_A)
has a genetically identical CRISPR/Cas system to ICP1_2004_A, and has been omitted for
simplicity. c, The RNA sequence of the CR1 and CR2 consensus direct repeat with the
partially palindromic sequence forming the predicted stem in the crRNA underlined.
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Figure 2. Genomic organization of PLE1, a representative V. cholerae PLE targeted by the
CRISPR/Cas system of ICP1-related phages
The integrase (int) is in blue, genes encoding hypothetical proteins (with numerical ORF
designations) are grey. The locations of protospacers incorporated into the CRISPR locus as
spacers 8 and 9 (S8 and S9 of ICP1_2011_A) are indicated in green above the map. The
locations of experimentally acquired protospacers are shown below the map in red.
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Figure 3. Sequence-based targeting by the ICP1 CRISPR/Cas system is essential for lytic growth
on V. cholerae PLE+
a, Disruption of the V. cholerae PLE target protospacer generating V. cholerae PLE(8*).
The 32 bp protospacer sequence is shaded in grey. b, The sensitivity of each strain (top row)
to ICP1 or ICP1ΔS9 (left column) is shown. Identity between the spacer and targeted
protospacer is indicated by the red and blue rectangles. The efficiency of plaquing (EOP,
which is the plaque count on the mutant host strain divided by that on the wild-type host
strain) is indicated. A dagger indicates that the EOP is 10−5 or 10−8 depending on the
presence of PLE in the host strain used for propagation as discussed in the text.
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